BACKGROUND: To determine the need for further therapy in patients with persistent or new pseudoaneurysms (PSAs) after splenic main coil embolization. METHODS: The institutional review board approved the study. The study group consisted of 400 hemodynamically stable patients (261 men, 139 women; mean age, 38.5 years) with blunt splenic injury. Abdominal computed tomography (ACT) images were assessed for grade of splenic injury, volume of hemoperitoneum, and evidence of splenic vascular injury including splenic vascular lesions and active bleeding. Splenic arteriography was performed for high-grade splenic injury and for ACT evidence of vascular injury. Follow-up ACT was reviewed for evidence of new or persistent PSAs after main coil embolization of the splenic artery. Medical records were reviewed to determine final outcome and any additional therapies used. RESULTS: Thirty-two patients had persistent (27) or new PSAs (5) after main coil embolization. Of these patients, two required splenectomy and one splenorrhaphy. The nonoperative salvage rate was 91% and the splenic salvage rate was 94%; this was comparable to the overall salvage rate of 95%. CONCLUSION: Splenic embolization remains a valuable adjunct in splenic salvage. Patients with persistent or new splenic PSAs after main coil embolization have similar splenic salvage rates to the overall cohort without additional therapies.
BACKGROUND: To determine the need for further therapy in patients with persistent or new pseudoaneurysms (PSAs) after splenic main coil embolization. METHODS: The institutional review board approved the study. The study group consisted of 400 hemodynamically stable patients (261 men, 139 women; mean age, 38.5 years) with blunt splenic injury. Abdominal computed tomography (ACT) images were assessed for grade of splenic injury, volume of hemoperitoneum, and evidence of splenic vascular injury including splenic vascular lesions and active bleeding. Splenic arteriography was performed for high-grade splenic injury and for ACT evidence of vascular injury. Follow-up ACT was reviewed for evidence of new or persistent PSAs after main coil embolization of the splenic artery. Medical records were reviewed to determine final outcome and any additional therapies used. RESULTS: Thirty-two patients had persistent (27) or new PSAs (5) after main coil embolization. Of these patients, two required splenectomy and one splenorrhaphy. The nonoperative salvage rate was 91% and the splenic salvage rate was 94%; this was comparable to the overall salvage rate of 95%. CONCLUSION: Splenic embolization remains a valuable adjunct in splenic salvage. Patients with persistent or new splenic PSAs after main coil embolization have similar splenic salvage rates to the overall cohort without additional therapies.
Authors: Douglas R Murken; Joshua J Weis; Geoffrey C Hill; Louis H Alarcon; Matthew R Rosengart; Raquel M Forsythe; Gary T Marshall; Timothy R Billiar; Andrew B Peitzman; Jason L Sperry Journal: Surgery Date: 2012-08-31 Impact factor: 3.982
Authors: Mauro Podda; Belinda De Simone; Marco Ceresoli; Francesco Virdis; Francesco Favi; Johannes Wiik Larsen; Federico Coccolini; Massimo Sartelli; Nikolaos Pararas; Solomon Gurmu Beka; Luigi Bonavina; Raffaele Bova; Adolfo Pisanu; Fikri Abu-Zidan; Zsolt Balogh; Osvaldo Chiara; Imtiaz Wani; Philip Stahel; Salomone Di Saverio; Thomas Scalea; Kjetil Soreide; Boris Sakakushev; Francesco Amico; Costanza Martino; Andreas Hecker; Nicola de'Angelis; Mircea Chirica; Joseph Galante; Andrew Kirkpatrick; Emmanouil Pikoulis; Yoram Kluger; Denis Bensard; Luca Ansaloni; Gustavo Fraga; Ian Civil; Giovanni Domenico Tebala; Isidoro Di Carlo; Yunfeng Cui; Raul Coimbra; Vanni Agnoletti; Ibrahima Sall; Edward Tan; Edoardo Picetti; Andrey Litvin; Dimitrios Damaskos; Kenji Inaba; Jeffrey Leung; Ronald Maier; Walt Biffl; Ari Leppaniemi; Ernest Moore; Kurinchi Gurusamy; Fausto Catena Journal: World J Emerg Surg Date: 2022-10-12 Impact factor: 8.165
Authors: Cornelis H van der Vlies; Otto M van Delden; Bastiaan J Punt; Kees J Ponsen; Jim A Reekers; J Carel Goslings Journal: Cardiovasc Intervent Radiol Date: 2010-07-29 Impact factor: 2.740
Authors: C H van der Vlies; J Hoekstra; K J Ponsen; J A Reekers; O M van Delden; J C Goslings Journal: Cardiovasc Intervent Radiol Date: 2011-03-24 Impact factor: 2.740